slides · global inventory
List
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 110,471
Current window 75,871-75,900
Pages 3,683
Rows per page 30
Component
75,871-75,900 of 110,471
10
Broadridge Financial Solutions | Results Presentation Deck | 30 slidesBroadridge Financial Solutions | Results Presentation Deck | 30 slides · Broadridge
Deck Investor relations Beat · SatisfactionLoop · Cost Of Inaction1 hit
12
The slide uses stacked bar charts to compare FY19 and FY20 revenues, alongside a bulleted list of highlights and a growth breakdown table.Broadridge Financial Solutions | Results Presentation Deck | 30 slides · Broadridge
Deck Investor relations Beat · SatisfactionLoop · Cost Of Inaction1 hit
14
Broadridge Financial Solutions | Results Presentation Deck | 30 slidesBroadridge Financial Solutions | Results Presentation Deck | 30 slides · Broadridge
Deck Investor relations Beat · SatisfactionLoop · Cost Of Inaction1 hit
02
Capri Holdings | Results Presentation Deck | 9 slidesCapri Holdings | Results Presentation Deck | 9 slides · Capri Holdings
Conference presentation Investor relations Beat · Attention1 hit
06
Capri Holdings | Results Presentation Deck | 9 slidesCapri Holdings | Results Presentation Deck | 9 slides · Capri Holdings
Conference presentation Investor relations Beat · Satisfaction1 hit
07
Capri Holdings | Results Presentation Deck | 9 slidesCapri Holdings | Results Presentation Deck | 9 slides · Capri Holdings
Conference presentation Investor relations Beat · Satisfaction1 hit
08
Capri Holdings | Results Presentation Deck | 9 slidesCapri Holdings | Results Presentation Deck | 9 slides · Capri Holdings
Conference presentation Investor relations Beat · Satisfaction1 hit
03
DraftKings | Results Presentation Deck | 11 slidesDraftKings | Results Presentation Deck | 11 slides · DraftKings
Conference presentation Investor relations Beat · Key TakeawaysLoop · So What Cascade1 hit
04
The chart normalizes GGR by population size to allow for a fair comparison across states with different demographics.DraftKings | Results Presentation Deck | 11 slides · DraftKings
Conference presentation Investor relations Beat · Key TakeawaysLoop · So What Cascade1 hit
05
DraftKings | Results Presentation Deck | 11 slidesDraftKings | Results Presentation Deck | 11 slides · DraftKings
Conference presentation Investor relations Beat · Proposed SolutionLoop · Cost Of Inaction1 hit
07
The slide uses a split-column layout to contrast financial performance with operational resilience.IBEX | IPO Presentation Deck | 23 slides · ibex
Pitch deck Investment bank 1 hit
23
Includes specific accounting adjustments labeled A through E.IBEX | IPO Presentation Deck | 23 slides · ibex
Pitch deck Investment bank 1 hit
08
The slide uses a process diagram to illustrate the mechanism of action for targeted protein degradation.Kymera | IPO Presentation Deck | 49 slides · Kymera
Pitch deck Investment bank 1 hit
12
The chart is a dot plot showing expression abundance across various tissues for different E3 ligases and targets, categorized by expression pattern (Ubiquitous, Restrictive, Selective).Kymera | IPO Presentation Deck | 49 slides · Kymera
Pitch deck Investment bank 1 hit
13
The slide uses a navigation sidebar to show the current step in a larger process (Pegasus platform).Kymera | IPO Presentation Deck | 49 slides · Kymera
Pitch deck Investment bank 1 hit
14
The slide uses 3D surface plots to illustrate the relationship between degrader concentration, binding affinity, and ternary complex formation, contrasting suboptimal vs. optimal outcomes.Kymera | IPO Presentation Deck | 49 slides · Kymera
Pitch deck Investment bank 1 hit
15
The slide uses a comparison table to show quantitative improvements in drug characteristics (potency, clearance, permeability, bioavailability).Kymera | IPO Presentation Deck | 49 slides · Kymera
Pitch deck Investment bank 1 hit
16
The slide uses a combination of a strategic framework (top) and biological pathway diagrams (bottom) to justify their R&D focus.Kymera | IPO Presentation Deck | 49 slides · Kymera
Pitch deck Investment bank 1 hit
17
The slide uses a color-coded system (blue for oncology, orange for inflammation/immunology) to distinguish therapeutic focus.Kymera | IPO Presentation Deck | 49 slides · Kymera
Pitch deck Investment bank 1 hit
19
Includes a diagram showing the mechanism of action for an IRAK4 degrader versus a kinase inhibitor.Kymera | IPO Presentation Deck | 49 slides · Kymera
Pitch deck Investment bank 1 hit
21
Data shows lower IC50 values for KT-474, indicating higher potency.Kymera | IPO Presentation Deck | 49 slides · Kymera
Pitch deck Investment bank 1 hit
22
The slide uses a heatmap to visualize the reduction of phosphorylation signals, highlighting the superior performance of the degrader KT-474 compared to other inhibitors.Kymera | IPO Presentation Deck | 49 slides · Kymera
Pitch deck Investment bank 1 hit
23
The slide shows efficacy in a psoriasis model (ear thickness) and target engagement (IRAK4 knockdown in skin and spleen) compared to vehicle and Clobetasol.Kymera | IPO Presentation Deck | 49 slides · Kymera
Pitch deck Investment bank 1 hit
28
The slide illustrates a biological pathway and the therapeutic intervention point for a drug candidate.Kymera | IPO Presentation Deck | 49 slides · Kymera
Pitch deck Investment bank 1 hit
29
The slide shows a dual-axis chart comparing protein degradation percentages and cell death percentages against drug concentration.Kymera | IPO Presentation Deck | 49 slides · Kymera
Pitch deck Investment bank 1 hit
30
Data shows dose-response curves for OCI-Ly10 and SUDHL2 cell lines.Kymera | IPO Presentation Deck | 49 slides · Kymera
Pitch deck Investment bank 1 hit
31
The slide demonstrates efficacy of a degrader molecule in a specific cancer model.Kymera | IPO Presentation Deck | 49 slides · Kymera
Pitch deck Investment bank 1 hit
33
The slide compares tumor volume over time for vehicle vs. two different doses of the lead compound across two administration routes.Kymera | IPO Presentation Deck | 49 slides · Kymera
Pitch deck Investment bank 1 hit
34
The slide uses a timeline-style header (IND to POC) combined with a table and bulleted list of study parameters.Kymera | IPO Presentation Deck | 49 slides · Kymera
Pitch deck Investment bank 1 hit
36
The slide uses a biological pathway diagram to illustrate the JAK-STAT signaling mechanism.Kymera | IPO Presentation Deck | 49 slides · Kymera
Pitch deck Investment bank 1 hit